Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Bioorg Med Chem Lett. 2012 Jan 21;22(5):2105–2109. doi: 10.1016/j.bmcl.2011.12.141

Table 1.

PSA mRNA level of LNCaP cells treated with the corresponding chalcone*

graphic file with name nihms355428u1.jpg
No. 1 2 3 4 5 6 7 8 9 10
a 0.78 0.13 0.41 0.44 0.14 0.24 0.21 0.64 0.67 0.61
b 0.37 0.05 0.09 0.52 0.06 0.10 0.08 0.09 0.31 0.26
c 0.43 0.32 0.67 0.59 0.30 0.21 0.21 0.38 0.58 0.36
d 0.68 0.46 0.56 0.71 0.22 0.35 0.32 0.43 0.71 0.71
e 0.63 0.35 0.36 0.51 0.44 0.33 0.30 0.39 0.34 0.29
f 0.81 0.13 0.29 0.27 0.29 0.15 0.10 0.19 0.32 0.35
g 0.47 0.23 0.48 0.44 0.16 0.11 0.33 0.24 0.24 0.18
h 0.74 0.40 0.20 0.20 0.31 0.16 0.06 0.75 0.81 0.15
i 0.52 0.31 0.48 1.61 0.26 0.80 0.20 0.40 0.60 0.51
j 0.50 0.48 0.19 0.62 0.23 0.16 0.16 0.36 0.35 0.30
*

PSA mRNA level was measured in LNCaP cells treated with the corresponding compound at 2.5 μM for 20 hr using real time RT-PCR. The PSA mRNA level is relative to DMSO-treated control cells in which PSA mRNA level is 1 (mean values, n = 3).